v3.26.1
Balance Sheet Details (Tables)
6 Months Ended
Jun. 30, 2026
Balance Sheet Related Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents

Cash, cash equivalents and restricted cash consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Cash and cash equivalents

 

$

270,026

 

 

$

120,863

 

Restricted cash

 

 

2,091

 

 

 

2,433

 

Total cash, cash equivalents and restricted cash

 

$

272,117

 

 

$

123,296

 

Schedule of Accounts Receivable, Net

Accounts receivable consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Trade receivables

 

$

15,973

 

 

$

13,715

 

Less: allowance for expected credit losses

 

 

(226

)

 

 

(284

)

Accounts receivable, net

 

$

15,747

 

 

$

13,431

 

Schedule of Inventories

Inventory consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Raw materials

 

$

8,031

 

 

$

8,631

 

Work-in-process

 

 

322

 

 

 

253

 

Finished goods

 

 

8,750

 

 

 

11,097

 

Total inventory

 

$

17,103

 

 

$

19,981

 

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Laboratory and manufacturing equipment

 

$

34,230

 

 

$

35,383

 

Leasehold improvements

 

 

13,783

 

 

 

14,050

 

Computer equipment

 

 

2,741

 

 

 

2,303

 

Internal-use software

 

 

13,096

 

 

 

13,118

 

Office furniture and fixtures

 

 

1,625

 

 

 

1,683

 

Property and equipment, gross

 

 

65,475

 

 

 

66,537

 

Less: accumulated depreciation and amortization

 

 

(50,735

)

 

 

(48,162

)

Construction-in-progress

 

 

560

 

 

 

900

 

Property and equipment, net

 

$

15,300

 

 

$

19,275

 

Accrued Liabilities

Accrued liabilities, which are included in current liabilities on the condensed consolidated balance sheets consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Accrued legal fees

 

$

8,219

 

 

$

3,513

 

Accrued litigation settlement indemnification (1)

 

 

7,500

 

 

 

 

Accrued compensation and related benefits

 

 

6,025

 

 

 

18,146

 

Uninvoiced receipts

 

 

1,713

 

 

 

941

 

Accrued restructuring

 

 

459

 

 

 

2,916

 

Accrued warranties

 

 

497

 

 

 

683

 

Accrued taxes

 

 

3,031

 

 

 

2,133

 

Other

 

 

2,164

 

 

 

1,451

 

Accrued liabilities

 

$

29,608

 

 

$

29,783

 

(1)
Represents the Company’s indemnification obligation to Illumina related to the litigation described in Note 6, Commitments and Contingencies. The Company paid this amount in July 2026.